date,title,source
Oct-17-18,Alexion Pharmaceuticals (ALXN) Q3 Earnings Preview: What to Know Ahead of the Release,Zacks
Oct-19-18,Berkshire Hathaway Stock Looks Cheap by Warren Buffetts Measure,Barrons.com
Oct-22-18,Alexion (ALXN) to Report Q3 Earnings: What's in the Cards?,Zacks
Oct-23-18,"Biotech Stocks Earnings Lineup for Oct 24: VRTX, ALXN & SRPT",Zacks
Oct-24-18,Edited Transcript of ALXN earnings conference call or presentation 24-Oct-18 12:00pm GMT,Thomson Reuters StreetEvents
Oct-24-18,Big Cap 20 Biotech Stock Dives On Mixed Third-Quarter Revenue,Investor's Business Daily
Oct-24-18,Alexion Pharmaceuticals Inc (ALXN) Q3 2018 Earnings Conference Call Transcript,Motley Fool
Oct-24-18,Alexion enters RNA gene-silencing field with $637M Dicerna deal,American City Business Journals
Oct-24-18,"[$$] Alexion 3Q Profit Up, Boosts Revenue Guidance",The Wall Street Journal
Oct-24-18,Alexion Pharmaceuticals (ALXN) Tops Q3 Earnings Estimates,Zacks
Oct-24-18,"Alexion stock rises 3% on Q3 beats, upbeat 2018 guidance",MarketWatch
Oct-24-18,Alexion: 3Q Earnings Snapshot,Associated Press
Oct-24-18,Alexion Reports Third Quarter 2018 Results,Business Wire
Oct-24-18,Alexion and Dicerna Announce Collaboration to Discover and Develop RNAi Therapies for Complement-Mediated Diseases,Business Wire
Oct-25-18,Edited Transcript of ALXN earnings conference call or presentation 24-Oct-18 12:00pm GMT,Thomson Reuters StreetEvents
Oct-31-18,"Biotech Stock Roundup: Celgene, Amgen, Vertex Impress in Q3, DRNA Soars on LLY Deal",Zacks
Oct-31-18,Alexion Pharmaceuticals Sees Hammer Chart Pattern: Time to Buy?,Zacks
Nov-01-18,Edited Transcript of ALXN earnings conference call or presentation 24-Oct-18 12:00pm GMT,Thomson Reuters StreetEvents
Nov-01-18,Biotech ETFs in Focus on String of Q3 Earnings Beat,Zacks
Nov-01-18,Alexion Announces Upcoming Data Presentations at American Society of Hematology Annual Meeting,Business Wire
Nov-06-18,Is Alexion Pharmaceuticals (ALXN) Stock Outpacing Its Medical Peers This Year?,Zacks
Nov-07-18,Alexion to Present at Credit Suisses 27th Annual Healthcare Conference,Business Wire
Nov-08-18,"Alexion Pharmaceuticals Dropped 19.4% in October, but the Business Remains Strong",Motley Fool
Nov-12-18,AVEO Pharmaceuticals (AVEO) Q3 Earnings & Revenues Top Mark,Zacks
Nov-15-18,Looking for a Growth Stock? Why It is Time to Focus on Alexion Pharmaceuticals (ALXN),Zacks
Nov-19-18,Amgen's Blincyto Gets Positive CHMP Opinion for Line Extension,Zacks
Nov-19-18,Seattle Genetics (SGEN) Looks Good: Stock Adds 5.6% in Session,Zacks
Nov-20-18,Alexion to Present at the Evercore ISI Healthcare Conference,Business Wire
Nov-20-18,IBD Stock Of The Day Breezes Toward Breakout On New Inhaler Uses,Investor's Business Daily
Nov-20-18,Emergent's (EBS) Zika Vaccine Candidate Meets Study Endpoint,Zacks
Nov-20-18,Fortress Biotech (FBIO) in Focus: Stock Moves 6.5% Higher,Zacks
Nov-21-18,Health Care Stocks Help This Fund Offset Tech Stocks' Dive,Investor's Business Daily
Nov-26-18,Should You Be Worried About Alexion Pharmaceuticals Incs (NASDAQ:ALXN) 1.7% Return On Equity?,Simply Wall St.
Nov-26-18,Keryx (KERX) Looks Good: Stock Adds 7.2% in Session,Zacks
Nov-27-18,Eyenovia Initiates Phase III Study for Mydriasis Candidate,Zacks
Nov-27-18,Rocket Pharmaceuticals (RCKT) in Focus: Stock Moves 7.2% Higher,Zacks
Nov-28-18,Aileron Inks Collaboration Deal With Pfizer for Cancer Combo,Zacks
Nov-30-18,Why Immunomedics (IMMU) Could Be Positioned for a Slump,Zacks
Dec-03-18,Comprehensive Positive Phase 3 Data for Alexions ALXN1210 in Patients with Paroxysmal Nocturnal Hemoglobinuria Presented at American Society of Hematology (ASH) Annual Meeting and Published in Blood,Business Wire
Dec-03-18,FDA Committee to Review Amgen's (AMGN) Osteoporosis Candidate,Zacks
Dec-03-18,Fate Therapeutics (FATE) Jumps: Stock Rises 8.9%,Zacks
Dec-04-18,Amgen's BiTE Immunotherapies Show Promise in Early Studies,Zacks
Dec-04-18,Global Blood Therapeutics' Voxelotor on Faster Approval Path,Zacks
Dec-10-18,Clovis Oncology (CLVS) in Focus: Stock Moves 6.9% Higher,Zacks
Dec-10-18,5 Top Drug/Biotech Merger & Acquisition Targets for 2019,Zacks
Dec-10-18,"Should You Avoid Alexion Pharmaceuticals, Inc. (ALXN)?",Insider Monkey
Dec-11-18,4 Biotech Stocks Investors Can Add to Their Portfolio in 2019,Zacks
Dec-11-18,Abeona Therapeutics (ABEO) in Focus: Stock Moves 5.5% Higher,Zacks
Dec-12-18,"The Zacks Analyst Blog Highlights: Gilead Sciences, Alexion Pharmaceuticals, Regeneron Pharmaceutical and Biogen",Zacks
Dec-14-18,"Future HQ of Alexion, PTC sells for $455M to Norges Bank, American Realty",American City Business Journals
Dec-14-18,AMAG to Acquire Ciraparantag Maker Perosphere Pharmaceuticals,Zacks
Dec-17-18,"Report finds growing pains for rare disease drugs, but local biotechs buck trend",American City Business Journals
Dec-18-18,Achillion Reports Positive Interim Data on Factor D Inhibitors,Zacks
Dec-18-18,Why Achillion Pharmaceuticals Is Cratering Again Today,Motley Fool
Dec-19-18,Vertex's (VRTX) 3rd Study on Pain Drug Meets Primary Endpoint,Zacks
Dec-20-18,Alexion Pharmaceuticals Enters Oversold Territory,Zacks
Dec-21-18,Alexion to Present at the Goldman Sachs 11th Annual Healthcare CEO Conference,Business Wire
Dec-21-18,Alexion Receives Early FDA Approval for ULTOMIRIS (Ravulizumab-cwvz) in Adults with Paroxysmal Nocturnal Hemoglobinuria (PNH),Business Wire
Dec-21-18,U.S. FDA approves Alexion Pharma's rare blood disorder drug,Reuters
Dec-21-18,U.S. FDA approves Alexion Pharma's blood disorder drug,Reuters
Dec-21-18,Agenus' Stock Up 23% on Immuno-Oncology Deal With Gilead,Zacks
Dec-21-18,Allakos (ALLK) Catches Eye: Stock Jumps 6.5%,Zacks
Dec-24-18,Alexion's Ultomiris Gets Early FDA Nod for Rare Blood Disorder,Zacks
Dec-24-18,Acorda Gets FDA Approval for Parkinson's Disease Drug Inbrija,Zacks
Dec-27-18,Alexion's (ALXN) Soliris Drives Growth Amid Pricing Pressure,Zacks
Jan-02-19,Alexion to Present at the 37th Annual J.P. Morgan Healthcare Conference,Business Wire
Jan-07-19,"Alexion to Report Fourth Quarter and Full Year 2018 Results on Monday, February 4, 2019",Business Wire
Jan-08-19,Edited Transcript of ALXN earnings conference call or presentation 24-Oct-18 12:00pm GMT,Thomson Reuters StreetEvents
Jan-08-19,Why Alexion Pharmaceuticals Stock Fell 21% in December,Motley Fool
Jan-08-19,4 Biotechs That Are Potential Buyouts Post Celgene Deal,Zacks
